Table 2 Unadjusted one-year ovarian cancer incidence and advanced stage incidence

One-year ovarian cancer incidence % (95% CI)

0.88

(0.84–0.91)

0.51

(0.40–0.63)

0.45

(0.33–0.61)

0.84

(0.81–0.87)

Normal CA-125

% (95% CI)

0.19

(0.18–0.21)

0.16

(0.10–0.24)

0.04

(0.01–0.12)

0.19

(0.17–0.20)

High CA-125

% (95% CI)

10.2

(9.8–10.6)

4.9

(3.8–6.3)

5.6

(4.0–7.6)

9.6

(9.3–10.1)

Median CA-125 level

(95% CI)

192

(172–218)

217

(74.3–589)

256

(111–701)

193

(173–218)

Advanced stage*

% (95% CI)*

57.6

(55.6–59.7)

58.3

(46.1–69.8)

66.7

(48.2–69.8)

57.6

(55.6–59.7)

Normal CA-125

% (95% CI)

18.2

(14.4–21.8)

18.8

(4.0–45.6)

66.7

(9.4–99.2)

18.0

(14.6–21.8)

High CA-125

% (95% CI)

67.8

(65.5–70.0)

69.6

(55.9–81.2)

66.7

(47.2–82.7)

67.7

(65.5–69.8)

Median CA-125 level

(95% CI)

496

(462–531)

751

(548–1,531)

308

(65.2–1,512)

498

(462–531)